Who is engaging with lateral flow testing for COVID-19 in the UK? The COVID-19 Rapid Survey of Adherence to Interventions and Responses (CORSAIR) study

Who is engaging with lateral flow testing for COVID-19 in the UK? The COVID-19 Rapid Survey of Adherence to Interventions and Responses (CORSAIR) study
复制标题

谁在英国从事 COVID-19 侧向层析检测?

DOI:
10.17605/osf.io/xn68v
复制
发表时间:
2021
期刊:
影响因子:
2.9
通讯作者:
J. Rubin
J. Rubin
中科院分区:
医学3区
文献类型:
--
作者:
Louise E. Smith;H. Potts;R. Amlȏt;N. Fear;S. Michie;J. Rubin

文献摘要

被引文献

相似文献

目的 调查侧向层析检测的采用情况、检测结果的报告以及与检测相关的心理、背景和社会人口因素。设计一系列四次每两周一次的在线横断面调查。设置数据收集时间为 2021 年 4 月 19 日至 2021 年 6 月 2 日。 参与者 居住在英格兰和苏格兰的年满 18 岁的人,不包括报告最近一次测试为聚合酶链反应 (PCR) 测试的人(n=6646,每次调查 n≈1600)。主要结果指标 在过去 7 天内至少完成一项侧向层析测试 (LFT)。结果 我们使用二元逻辑回归来调查与至少参加一次 LFT 相关的因素。接受检测的增加与接种疫苗(调整后 OR (aOR)=1.52–2.45,95% CI 1.25 至 3.07,按疫苗剂量分别分析)、就业(aOR=1.94,95% CI 1.63 至 2.32)、上周外出工作(aOR=2.30,95% CI 1.94 至 2.32)相关。 2.73)并在较早采用 LFT 的行业工作(aOR=2.54,95% CI 2.14 至 3.02)。上周报告主要 COVID-19 症状的人的摄入量较高(aOR=1.89,95% CI 1.34 至 2.66)。听说过更多有关 LFT(aOR=2.28,95% CI 2.06 至 2.51)并知道自己有资格接受常规 LFT(aOR=2.98,95% CI 2.35 至 3.78)的人也更有可能进行测试。与不参加检测相关的因素包括同意您无需进行 COVID-19 检测,除非您曾接触过病例(aOR=0.51,95% CI 0.47 至 0.55)。结论 侧向层析检测的采用率较低。鼓励通过工作场所和学习场所进行测试可能会增加采用率,但应注意不要给员工和学生施加压力。增加人们对每个人都有资格接受定期无症状检测的认识并解决常见的误解可能会推动采用。
Objectives To investigate uptake of lateral flow testing, reporting of test results and psychological, contextual and socio-demographic factors associated with testing. Design A series of four fortnightly online cross-sectional surveys. Setting Data collected from 19 April 2021 to 2 June 2021. Participants People living in England and Scotland, aged 18 years or over, excluding those who reported their most recent test was a polymerase chain reaction (PCR) test (n=6646, n≈1600 per survey). Main outcome measures Having completed at least one lateral flow test (LFT) in the last 7 days. Results We used binary logistic regressions to investigate factors associated with having taken at least one LFT. Increased uptake of testing was associated with being vaccinated (adjusted ORs (aORs)=1.52–2.45, 95% CI 1.25 to 3.07, analysed separately by vaccine dose), employed (aOR=1.94, 95% CI 1.63 to 2.32), having been out to work in the last week (aOR=2.30, 95% CI 1.94 to 2.73) and working in a sector that adopted LFT early (aOR=2.54, 95% CI 2.14 to 3.02) . Uptake was higher in people who reported cardinal COVID-19 symptoms in the last week (aOR=1.89, 95% CI 1.34 to 2.66). People who had heard more about LFTs (aOR=2.28, 95% CI 2.06 to 2.51) and knew they were eligible to receive regular LFTs (aOR=2.98, 95% CI 2.35 to 3.78) were also more likely to have tested. Factors associated with not taking a test included agreeing that you do not need to test for COVID-19 unless you have come into contact with a case (aOR=0.51, 95% CI 0.47 to 0.55). Conclusions Uptake of lateral flow testing is low. Encouraging testing through workplaces and places of study is likely to increase uptake, although care should be taken not to pressurise employees and students. Increasing knowledge that everyone is eligible for regular asymptomatic testing and addressing common misconceptions may drive uptake.